+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Fetal Bovine Serum Market (2023-2028) by Product, Application, End User, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 189 Pages
  • February 2024
  • Infogence Global Research
  • ID: 5650764

Increasing use of serum in a wide range of applications like cloning, animal diagnostics, stem-cell research, vaccine production, and many others

The Global Fetal Bovine Serum Market is estimated to be USD 996.62 Mn in 2023 and is expected to reach USD 1313.69 Mn by 2028 growing at a CAGR of 5.68%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Fetal Bovine Serum Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Fetal Bovine Serum Market is segmented based on Product, Application, End User, and Geography.
  • By Product, the market is classified into Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, and Stem Cell.
  • By Application, the market is classified into Cell Culture Media, Diagnostics, Drug Discovery, Human and Animal Vaccine Production, In Vitro Fertilization, and Other.
  • By End User, the market is classified into Industry, Research & Academi and Research & Academic Institutes.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Atlas Biologicals, Bio-Techne, Bio-West, Bovogen Biologicals, Corning, GE Healthcare, Himedia Laboratories, ]etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Fetal Bovine Serum Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Fetal Bovine Serum Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Fetal Bovine Serum Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Demand from Traditional Users of Serum
4.1.2 Growth in Investments and Funding for Research Interventions
4.1.3 High Incidence and Mortality Associated with Coagulation Disorders
4.2 Restraints
4.2.1 Decrease in Cattle Herd Population due to the Increased Demand of Dairy and Meat Products
4.2.2 High Cost and Chances of Viral Presence in the Product
4.3 Opportunities
4.3.1 Increasing Culture Media Consumption in Developing Countries
4.3.2 Increase in R&D Activities towards the Introduction of New Biopharmaceuticals
4.3.3 Untapped Potential of Emerging Markets
4.4 Challenges
4.4.1 Lack of Skilled Personnel
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Fetal Bovine Serum Market, By Product
6.1 Introduction
6.2 Charcoal Stripped
6.3 Chromatographic
6.4 Dialyzed Fetal Bovine Serum
6.5 Exosome Depleted
6.6 Stem Cell
7 Global Fetal Bovine Serum Market, By Application
7.1 Introduction
7.2 Cell Culture Media
7.3 Diagnostics
7.4 Drug Discovery
7.5 Human and Animal Vaccine Production
7.6 In Vitro Fertilization
7.7 Other
8 Global Fetal Bovine Serum Market, By End User
8.1 Introduction
8.2 Industry
8.3 Research & Academic Institutes
9 Americas’ Fetal Bovine Serum Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas
10 Europe’s Fetal Bovine Serum Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe
11 Middle East and Africa’s Fetal Bovine Serum Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA
12 APAC’s Fetal Bovine Serum Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 Atlas Biologicals
14.2 Bio-Techne
14.3 Bio-West
14.4 Bovogen Biologicals
14.5 Corning
14.6 GE Healthcare
14.7 Himedia Laboratories
14.8 Merck
14.9 PAN-Biotech
14.10 Rocky Mountain Biologicals
14.11 Rocky Mountain Biologicals
14.12 Sanofi
14.13 Sartorius
14.14 Sera Scandia
14.15 TCS Biosciences
14.16 Thermo Fisher Scientific
14.17 Thermo Fisher Scientific
14.18 ZenBio
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • Atlas Biologicals
  • Bio-Techne
  • Bio-West
  • Bovogen Biologicals
  • Corning
  • GE Healthcare
  • Himedia Laboratories
  • Merck
  • PAN-Biotech
  • Rocky Mountain Biologicals
  • Rocky Mountain Biologicals
  • Sanofi
  • Sartorius
  • Sera Scandia
  • TCS Biosciences
  • Thermo Fisher Scientific
  • Thermo Fisher Scientific
  • ZenBio